Latham & Watkins advised Advanced Micro Devices – AMD on the acquisition Of ZT Systems advised by Paul Weiss. AMD (NASDAQ: AMD) signed a definitive agreement...
Advanced Micro Devices (AMD)’s $4.9 Billion Acquisition Of ZT Systems
scPharmaceuticals’ $125 Million Senior Secured Term Loan
Latham & Watkins advised scPharmaceuticals on the deal. scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to...
Nano Dimension’s Acquisition of Desktop Metal
Greenberg Traurig and Sullivan & Worcester are advising Nano Dimension, while Latham & Watkins and Shibolet & Co. are advising Desktop Metal on the deal. Nano...
Chiesi Group’s Collaboration with Gossamer Bio
Ropes & Gray advised Chiesi Group on the transaction, and Latham & Watkins advised Gossamer Bio. Chiesi Group announced it has entered into a global collaboration...
Reddit’s US$748 Million Initial Public Offering
Latham & Watkins LLP represented Reddit in the offering. Reddit, Inc., a community of communities, has announced the pricing of its initial public offering of an...
Boston Scientific’s $850 Million Acquisition of Relievant MedSystems
Faegre Drinker advised Boston Scientific, and Latham & Watkins advised Relievant MedSystems on the deal. Boston Scientific Corporation (NYSE: BSX) announced it has entered into a...
Otsuka’s Collaboration with ShapeTX
Latham & Watkins advised ShapeTX on the deal. Otsuka Pharmaceutical Co., Ltd. and ShapeTX announced a multi-target collaboration to develop intravitreally-delivered adeno-associated viruses (AAVs) for ocular...
Neumora Therapeutics’ $250.1 Million Initial Public Offering
Latham & Watkins advised Neumora, and Cooley advised the underwriters. Neumora Therapeutics, Inc. announced the pricing of its initial public offering of 14,710,000 shares of its common...
Endava’s Acquisition of TLM
Latham & Watkins Advises TLM in Acquisition by Endava. Endava, a global provider of digital transformation, agile development and intelligent automation services, acquired TLM Partners, Inc...
NextRoll’s $50 Million Financing Deal From Capital IP
Latham & Watkins advises NextRoll in US$50 million financing deal from Capital IP. NextRoll, the San Francisco-based marketing technology company delivering products for ambitious marketers to...
Guardant Health’s Upsized Public Offering of Common Stock
Latham & Watkins Advises Guardant Health in Pricing of Upsized Public Offering of Common Stock. Guardant Health, Inc., a leading precision oncology company, has announced the pricing...
Vaxcyte’s $500 Million Public Offering
Cooley advises Vaxcyte on the offering, and Latham & Watkins advises the underwriters. Vaxcyte, Inc. (Nasdaq: PCVX) has announced the pricing of an underwritten public offering...